lomustine/procarbazine/vincristine

Known as: CCNU/PCB/VCR, PCV 
A combination of agents containing lomustine, procarbazine and vincristine.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2018
051019922018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
A seven-valent pneumococcal conjugate vaccine (PCV7) introduced in the United States in 2000 has been shown to reduce invasive… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE The standard of care for anaplastic gliomas is surgery followed by radiotherapy. The NOA-04 phase III trial compared… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
A retrospective evaluation of single agent bevacizumab in adults with recurrent glioblastoma (GBM) with an objective of… (More)
  • table 2
  • table 3
  • figure 1
Is this relevant?
2004
2004
In pneumococcal conjugate vaccines (PCVs), polysaccharide antigens are often conjugated to protein carriers related to other… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2000
2000
Although the efficacy of the nitrosourea-based combination chemotherapy procarbazine, N-(2-chloroethyl)-N*cyclohexyl-N-nitrosurea… (More)
  • table 1
  • figure 2
  • figure 1
  • table 2
  • table 3
Is this relevant?
1999
1999
PURPOSE To conduct a Phase II study to evaluate the long-term efficacy and safety of high-dose 5'-bromodeoxyuridine (BrdU) and… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
OBJECTIVES To determine the response rate and factors correlated with response of oligodendroglial tumors to procarbazine… (More)
Is this relevant?
1998
1998
BACKGROUND The regimen of procarbazine, CCNU, and vincristine is active against gliomas. Previous attempts at dose… (More)
Is this relevant?
1995
1995
PURPOSE To conduct a Phase II study to evaluate the long-term efficacy and safety of radiotherapy combined with intravenous… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Malignant oligodendrogliomas have been shown to be responsive to chemotherapy. The authors administered systemic chemotherapy to… (More)
Is this relevant?